Search results for "Resuscitation"

showing 10 items of 163 documents

Small volume resuscitation with tempol is detrimental during uncontrolled hemorrhagic shock in rats.

2005

In a previous study, titration of a hypertonic saline (HTS) solution during severe uncontrolled hemorrhagic shock (UHS) failed to reduce mortality. In a separate study, a novel antioxidant, polynitroxylated albumin (PNA) plus tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), infused during shock increased long-term survival. We hypothesized that combining potent antioxidants with a hypertonic solution during UHS would preserve the logistical advantage of small volume resuscitation and improve survival.An UHS outcome model in rats was used. UHS phase I (90 min) included blood withdrawal of 30 ml/kg over 15 min, followed by tail amputation for uncontrolled bleeding. At 20 min, rats wer…

MaleMean arterial pressureResuscitationResuscitationEmergency NursingHydroxyethyl starchShock HemorrhagicAntioxidantsCyclic N-OxidesRats Sprague-DawleyIntensive careAlbuminsMedicineAnimalsSaline Solution Hypertonicbusiness.industryAlbuminDrug SynergismHypertonic salineRatsSurvival RateDisease Models AnimalHematocritHemostasisShock (circulatory)AnesthesiaEmergency MedicineFluid TherapySpin Labelsmedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugResuscitation
researchProduct

Titrated hypertonic/hyperoncotic solution for hypotensive fluid resuscitation during uncontrolled hemorrhagic shock in rats.

2002

In volume- or pressure-controlled hemorrhagic shock (HS) a bolus intravenous infusion of hypertonic/hyperoncotic solution (HHS) proved beneficial compared to isotonic crystalloid solutions. During uncontrolled HS in animals, however, HHS by bolus increased blood pressure unpredictably, and increased blood loss and mortality. We hypothesized that a titrated i.v. infusion of HHS, compared to titrated lactated Ringer's solution (LR), for hypotensive fluid resuscitation during uncontrolled HS reduces fluid requirement, does not increase blood loss, and improves survival.We used our three-phased uncontrolled HS outcome model in rats. HS phase I began with blood withdrawal of 3 ml/100g over 15 mi…

MaleMean arterial pressureResuscitationRinger's LactateResuscitationBlood PressureHemorrhageEmergency NursingHydroxyethyl starchShock HemorrhagicRats Sprague-DawleyBolus (medicine)Intensive careMedicineAnimalsInfusions IntravenousSaline Solution Hypertonicbusiness.industryOsmolar ConcentrationTitrimetrySurvival AnalysisRatsDisease Models AnimalBlood pressureTreatment OutcomeHemostasisAnesthesiaEmergency MedicineTonicityFluid TherapyHypotensionIsotonic SolutionsCardiology and Cardiovascular MedicinebusinessBlood Chemical Analysismedicine.drugResuscitation
researchProduct

Effects of a single-dose hypertonic saline hydroxyethyl starch on cerebral blood flow, long-term outcome, neurogenesis, and neuronal survival after c…

2012

The beneficial effects of hypertonic saline on neuronal survival and on cerebral blood flow have been shown in several animal models of global and focal brain ischemia. Because of the potential benefits of hypertonic solutions, it is hypothesized that hydroxyethyl starch enhances cerebral blood flow and improves long-term outcome after cardiac arrest and cardiopulmonary resuscitation in an animal model.Laboratory animal study.University animal research laboratory.Fifty-nine male Sprague-Dawley rats.Rats were randomized to receive either 7.2% saline/6% hypertonic saline hydroxyethyl starch (4 mL/kg) or vehicle (NaCl 0.9 %) after 9 mins of asphyxic cardiac arrest and cardiopulmonary resuscita…

MaleNeurogenesismedicine.medical_treatmentPlasma Substitutesmacromolecular substancesHydroxyethyl starchCritical Care and Intensive Care MedicineHydroxyethyl Starch DerivativesRats Sprague-DawleyBrain ischemiaRandom AllocationAnimalsMedicineCardiopulmonary resuscitationBeneficial effectsNeuronsbusiness.industryNeurogenesisBrainmedicine.diseaseCardiopulmonary ResuscitationRatsHypertonic salineBromodeoxyuridineCerebral blood flowCerebrovascular CirculationAnesthesiaHeart Arrest InducedTonicitybusinessmedicine.drugCritical Care Medicine
researchProduct

Successful Management of Fulminant Pulmonary Embolism Using a Novel Portable Extracorporeal Life Support System

2010

A 46-year-old man presented to the emergency room with pain in his left leg, dyspnea, and general cyanosis. During examination he collapsed and required resuscitation. Under suspicion of pulmonary embolism, a new portable "click 'n run" extracorporeal life support system (LIFEBRIDGE-B(2)T [Medizintechnik AG, Ampfing, Germany]) was implanted by the femoral vessels under resuscitation within 15 minutes of presentation. The patient was stabilized, despite severe decompensation (pH, 6.8), and could be transferred for a computed tomographic scan, which confirmed massive pulmonary embolism. Still connected to the life support system, the patient was transferred to the operating room. After a pulm…

MalePulmonary and Respiratory MedicineResuscitationmedicine.medical_specialtymedicine.medical_treatmentFulminantAdvanced Cardiac Life SupportExtracorporealPulmonary thrombectomymedicineHumansDecompensationEmergency Treatmentbusiness.industryRemission InductionOrgan dysfunctionMiddle Agedmedicine.diseaseSurgeryPulmonary embolismLife supportSurgerymedicine.symptomPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessThe Annals of Thoracic Surgery
researchProduct

Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin

2015

The prognostic value of copeptin, the C-terminal fragment of the precursor protein of vasopressin which is released upon stress, and hypotension in pulmonary embolism is unknown, especially if combined with biomarkers reflecting different pathophysiological axes such as myocardial injury (high-sensitivity troponin T (hsTnT)) and stretch (N-terminal pro-brain natriuretic peptide (NT-proBNP)).We prospectively studied 268 normotensive pulmonary embolism patients included in a single-centre cohort study.Patients with an adverse 30-day outcome (5.6%) had higher copeptin levels than patients with a favourable course (median (interquartile range) 51.8 (21.6–90.8) versus 13.2 (5.9–39.3) pmol·L−1; p…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classVentricular Dysfunction Right030204 cardiovascular system & hematologyRisk AssessmentCohort Studies03 medical and health sciencesCatecholamines0302 clinical medicineCopeptinTroponin TInterquartile rangeInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansProspective StudiesProspective cohort studyAgedTroponin Tbusiness.industryGlycopeptidesMiddle AgedPrognosismedicine.diseaseRespiration ArtificialCardiopulmonary ResuscitationPeptide Fragments3. Good healthPulmonary embolism030228 respiratory systemCardiologyFemalePulmonary EmbolismRisk assessmentbusinessBiomarkersCohort studyEuropean Respiratory Journal
researchProduct

Mortality in patients with acute aortic dissection type A: analysis of pre- and intraoperative risk factors from the German Registry for Acute Aortic…

2015

Acute aortic dissection type A (AADA) is an emergency with excessive mortality if surgery is delayed. Knowledge about independent predictors of mortality on surgically treated AADA patients is scarce. Therefore, this study was conducted to identify pre- and intraoperative risk factors for death.Between July 2006 and June 2010, 2137 surgically treated patients with AADA were enrolled in a multicentre, prospective German Registry for Acute Aortic Dissection type A (GERAADA), presenting perioperative status, operative strategies, postoperative outcomes and AADA-related risk factors for death. Multiple logistic regression analysis was performed to identify the influence of different parameters …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentOperative TimeMyocardial IschemiaIschemiaDisease030204 cardiovascular system & hematologyBrain Ischemia03 medical and health sciences0302 clinical medicineIschemiaRisk FactorsGermanymedicine.arteryHumansMedicineProspective StudiesRegistriesCardiopulmonary resuscitationIntraoperative ComplicationsAortic dissectionLegAortaAortic Aneurysm Thoracicbusiness.industryGeneral MedicineOdds ratioPerioperativeMiddle Agedmedicine.diseaseSurgeryAortic DissectionTreatment OutcomeHemiparesis030228 respiratory systemAcute DiseaseFemaleSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Risk factors influencing the outcome after surgical treatment of complicated deep sternal wound complications.

2003

Background: Median sternotomy is the most frequently used incision for cardiac procedures but carries a substantial risk for deep sternal wound infections and/or sternal dehiscence. In contrast to previous studies that examined risk factors for sternal infections this study evaluates factors that lead to poor outcome after surgical revision of the non healing sternum. Methods: Between 1985 and 1999, 193 adults (mean age 64 ± 9 years, m/f = 3/1) necessitated sternal revisions (incidence 1.93%). Pre-, intra- and post-operative risk factors were evaluated for their influence on the outcome after sternal revision. Results: 65 of the 193 patients had a complicated course: ten (5.2%) died due to …

MaleReoperationmedicine.medical_specialtySternumTime Factorsmedicine.medical_treatmentFistulaBody Mass IndexSepsisDiabetes ComplicationsPostoperative ComplicationsHypothermia InducedRisk FactorsSurgical Wound DehiscenceMedicineHumansSurgical Wound InfectionRadiology Nuclear Medicine and imagingCardiopulmonary resuscitationRenal InsufficiencyGlucocorticoidsAgedbusiness.industryIncidence (epidemiology)OsteomyelitisHazard ratioSmokingAge FactorsOdds ratioMiddle Agedmedicine.diseaseRespiration ArtificialCardiopulmonary ResuscitationSurgeryAnti-Bacterial AgentsMedian sternotomySurgeryFemalebusinessCardiology and Cardiovascular MedicineCardiovascular surgery (London, England)
researchProduct

Anti-Inflammatory Treatment with Standardized Human Serum Protein Solution Reduces Local and Systemic Inflammatory Response after Hemorrhagic Shock

2005

<i>Objective:</i> Reperfusion after hemorrhagic shock leads to local and systemic inflammatory response. This study evaluates the effect of a short-term treatment with standardized human serum protein solution (SPS) on the local and systemic inflammatory response in the mesenteric microcirculation in the rat. <i>Methods:</i> Spontaneously breathing animals underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume-controlled hemorrhagic shock was set by arterial blood withdrawal (2.5 ml/100 g body weight for 60 min), followed by reperfusion for 4 h. SPS (n = 10) or saline 0.9% (controls, n = 1…

MaleResuscitationCentral Venous PressureInflammatory responseAnti-Inflammatory AgentsHemodynamicsBlood PressureInflammationShock HemorrhagicMicrocirculationRats Sprague-DawleyHeart RateLeukocytesAnimalsMedicinebusiness.industryMicrocirculationHemodynamicsBlood ProteinsBlood proteinsRatsBlood pressureShock (circulatory)ImmunologySurgeryBlood Gas Analysismedicine.symptombusinessEuropean Surgical Research
researchProduct

C1-Esterase-Inhibitor Treatment at Early Reperfusion of Hemorrhagic Shock Reduces Mesentery Leukocyte Adhesion and Rolling

2001

Objective: Complement activation probably plays a pathogenic role in multiple organ failure in shock. This study evaluates the effects of C1-esterase-inhibitor treatment on leukocyte-endothelial interaction in the mesenteric microcirculation in hemorrhagic shock. Methods: Rats underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume controlled hemorrhagic shock was provoked by arterial blood withdrawal (2.5 mL/ 100 g body wt. for 60 minutes) followed by a 4-hour reperfusion period. C1-INH (100 IU/kg body wt. i.v.) or 0.9% NaCl i.v. were administered as a bolus at the beginning of reperfusion. Reperfusion time mimic…

MaleResuscitationPhysiologymedicine.medical_treatmentComplement C1 Inactivator ProteinsShock HemorrhagicMicrocirculationRats Sprague-DawleyComplement inhibitorBolus (medicine)IleumPhysiology (medical)Cell AdhesionLeukocytesmedicineAnimalsSplanchnic CirculationMolecular BiologySalinebusiness.industryMicrocirculationHemodynamicsRatsComplement systemChemotaxis LeukocyteKineticsAnesthesiaReperfusionArterial bloodEndothelium VascularCardiology and Cardiovascular MedicinebusinessIntravital microscopyMicrocirculation
researchProduct

Ultra-low tidal volume ventilation-A novel and effective ventilation strategy during experimental cardiopulmonary resuscitation.

2018

Abstract Background The effects of different ventilation strategies during CPR on patient outcomes and lung physiology are still poorly understood. This study compares positive pressure ventilation (IPPV) to passive oxygenation (CPAP) and a novel ultra-low tidal volume ventilation (ULTVV) regimen in an experimental ventricular fibrillation animal model. Study design Prospective randomized controlled trial. Animals 30 male German landrace pigs (16–20 weeks). Methods Ventricular fibrillation was induced in anesthetized and instrumented pigs and the animals were randomized into three groups. Mechanical CPR was initiated and ventilation was either provided by means of standard IPPV (RR: 10/min,…

MaleResuscitationSwinemedicine.medical_treatmentRespiratory physiology030204 cardiovascular system & hematologyEmergency NursingLung injuryAdvanced Cardiac Life SupportReal-Time Polymerase Chain ReactionIntermittent Positive-Pressure Ventilation03 medical and health sciencesRandom Allocation0302 clinical medicinemedicineTidal VolumeAnimalsHumansCardiopulmonary resuscitationTidal volumeAnalysis of VarianceContinuous Positive Airway Pressurebusiness.industryPulmonary Gas Exchange030208 emergency & critical care medicineOxygenationLung Injurymedicine.diseaserespiratory tract diseasesDisease Models AnimalTreatment OutcomeAnesthesiaVentricular fibrillationEmergency MedicineBreathingCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct